E475-0095 Screening compound: N-[3-(4-methylpiperidin-1-yl)propyl]-11-oxo-6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide

E475-0095 Screening compound: N-[3-(4-methylpiperidin-1-yl)propyl]-11-oxo-6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide
E475-0095 Screening compound: N-[3-(4-methylpiperidin-1-yl)propyl]-11-oxo-6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E475-0095
N-[3-(4-methylpiperidin-1-yl)propyl]-11-oxo-6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E475-0095

Molecular Formula

C22H30N4O2 (C22 H30 N4 O2)

Compound Name

N-[3-(4-methylpiperidin-1-yl)propyl]-11-oxo-6H,7H,8H,9H,11H-pyrido[2,1-b]quinazoline-3-carboxamide

IUPAC name

N-[3-(4-methylpiperidin-1-yl)propyl]-11-oxo-6H7H8H9H11H-pyrido[21-b]quinazoline-3-carboxamide

SMILES

CC1CCN(CCCNC(c(cc2)cc(N=C3N4CCCC3)c2C4=O)=O)CC1

InChI

InChI=1S/C22H30N4O2/c1-16-8-13-25(14-9-16)11-4-10-23-21(27)17-6-7-18-19(15-17)24-20-5-2-3-12-26(20)22(18)28/h6-7,15-16H,2-5,8-14H2,1H3,(H,23,27)

InChI Key

KTLPTGJPYRZTIG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14855280

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

382.51

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

1.645

Distribution Coefficient, logD

-0.815

Water Solubility, LogSw

-2.52

Polar Surface Area

54.626

Acid Dissociation Constant (pKa)

13.94

Base Dissociation Constant (pKb)

9.86

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

59.10

E475-0095 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with E475-0095 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E475-0095?
Check Price and Availability of E475-0095, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E475-0095 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E475-0095
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E475-0095
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E475-0095 available by request